Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy

Xingqin Zhou; Yazhou Chang; Jing Qian; Chaoyan Shen; Jie Han; Hongyu Zhao; Renan Chang

doi:10.12659/MSM.929474

31 July 2021 : Clinical Research

Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy

Xingqin Zhou^1BCE, Yazhou Chang^2BD, Jing Qian^1BF, Chaoyan Shen^1DEF, Jie Han^1EF, Hongyu Zhao^1DF, Renan Chang^3AG*

DOI: 10.12659/MSM.929474

Med Sci Monit 2021; 27:e929474

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Percentage of all kinds of therapeutic outcomes between the Study Group and the Historical Group. CR – complete response; PR – partial response; SD – stable disease; PD – progressive disease. * P<0.05 represents statistical difference.

Back to the Article

Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy

Your Privacy